Back to Journals » Clinical Ophthalmology » Volume 18

Addressing Technical Failures in a Diabetic Retinopathy Screening Program [Response to Letter]

Authors Brennan IG, Kelly SR, McBride E, Garrahy D , Acheson R, Harmon J, McMahon S, Keegan DJ, Kavanagh H, O'Toole L 

Received 18 March 2024

Accepted for publication 19 March 2024

Published 27 March 2024 Volume 2024:18 Pages 951—952

DOI https://doi.org/10.2147/OPTH.S469413



Ian Gerard Brennan,1,* Stephen R Kelly,1,* Edel McBride,2 Darragh Garrahy,1 Robert Acheson,2 Joanne Harmon,2 Shane McMahon,2 David J Keegan,1 Helen Kavanagh,1 Louise O’Toole2

1Diabetic RetinaScreen, National Screening Service, Health Service Executive, Dublin, Ireland; 2Diabetic Retinal Screening Service, NEC Care, Cork City, Co. Cork, Ireland

*These authors contributed equally to this work

Correspondence: Louise O’Toole, NEC Care, Matthew House-3rd Floor, Fr Matthew Street, Cork City, Co. Cork, T12 TN56, Ireland, Email [email protected]


View the original paper by Dr Brennan and colleagues

This is in response to the Letter to the Editor


Dear editor

We appreciate the authors’ comments on our manuscript.1

Our paper focuses on addressing technical failures when capturing fundal images in a nationwide community-based diabetic retinopathy screening program. Patients undergo colour photography, and those with maculopathy and best corrected visual acuity (BCVA) of 6/18 or better also have digital surveillance using a combination of colour digital photography and optical coherence tomography (OCT). Patients with maculopathy and BCVA of worse than 6/18 or with sight-threatening retinopathy i.e. pre-proliferative or proliferative retinopathy are referred to a medical retinal ophthalmologist in the nearest treatment centre.

While OCT during screening in the community can rule out macular pathology and avoid referral to a treatment centre, the retinopathy grade remains unknown if the images cannot be graded. Patients with ungradable images or who are unable to position for photography, are referred to a local optometrist for further assessment using slit lamp biomicroscopy.

If further investigation is required, the patient is then referred to a medical retinal ophthalmologist in the patient’s nearest treatment centre where comprehensive multimodal imaging can be performed.

Disclosure

The authors report no conflicts of interest in this communication.

Reference

1. Budu ET, Idrus HH. Addressing technical failures in a diabetic retinopathy screening program [Letter]. Clin Ophthalmol. 2024;18:849–850. doi:10.2147/OPTH.S465913

Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.